Revenue of 65,131 million yen (Year-over-Year +5.9%), operating profit of 6,168 million yen (+19.3%), and EBITDA of 11,473 million yen (+14.7%). Full-year forecast remains unchanged for now and progress is broadly in line with expectations. Key contributing segments include Vision Care, 1DAY, and Ortho-K.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7780","jir_company_name":"Menicon Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7780-20261113-02.pdf","jir_short_summary":"Revenue of 65,131 million yen (Year-over-Year +5.9%), operating profit of 6,168 million yen (+19.3%), and EBITDA of 11,473 million yen (+14.7%). Full-year forecast remains unchanged for now and progress is broadly in line with expectations. Key contributing segments include Vision Care, 1DAY, and Ortho-K.","jir_summary":"### Business Performance Overview\nFor the second quarter of the fiscal year ending March 2027, consolidated revenue was 65,131 million yen, a Year-over-Year increase of 5.9%. The main drivers were expansion of 1DAY membership and increased overseas sales. In addition, selling, general and administrative expenses were contained through cost-structure reviews, resulting in operating profit expanding to 6,168 million yen (+19.3%). EBITDA was 11,473 million yen (+14.7%), and EBITDA margin improved by 1.3 percentage points year-over-year. Net income at the end was 3,578 million yen, exceeding the same period last year.\n\n### Outlook and Key Uncertainties\nThe full-year forecast has not been substantially revised based on current progress, and foreign exchange assumptions at the reporting time are applied. Market factors that may affect results include the weak yen, regional economic conditions, sustainability of 1DAY membership growth, and region-specific demand for Ortho-K related products. Attention should also be paid to cost impacts associated with ongoing investments such as capital expenditures at the Malaysia plant.","jir_financial_highlights":"Revenue: 65,131 (Year-over-Year +5.9%)\nGross Profit: 34,915 (Year-over-Year +4.9%)\nOperating Profit: 6,168 (Year-over-Year +19.3%)\nEBITDA: 11,473 (Year-over-Year +14.7%)\nOrdinary Income: 5,620 (Year-over-Year +12.0%)\nNet Income Attributable to Owners of Parent: 3,578 (Year-over-Year +13.5%)","jir_category":"","jir_hashtags":"#ShareBuybackRelated, #Earnings, #Vision2030, #1DAY, #OrthoK","jir_key_figures":"Revenue: 65,131 million yen\nOperating Profit: 6,168 million yen\nEBITDA: 11,473 million yen","jir_meta_title":"Menicon Co., Ltd. | Second Quarter Financial Summary for FY Ending March 2027 \u2014 Revenue 65,131 million yen, Operating Profit 6,168 million yen","jir_meta_description":"Menicon Co., Ltd. Q2 financial summary for the fiscal year ending March 2027: Revenue 65,131 million yen (YoY +5.9%), Operating Profit 6,168 million yen (+19.3%), EBITDA 11,473 million yen (+14.7%). Full-year forecast on track; includes FX assumptions and segment breakdowns.","jir_og_title":"Menicon Co., Ltd. | Q2 Financial Summary for FY Ending March 2027","jir_og_description":"Menicon Co., Ltd.'s Q2 results show solid performance with revenue of 65,131 million yen, operating profit of 6,168 million yen, and EBITDA of 11,473 million yen. Full-year forecast remains unchanged. Key areas to watch: expansion of 1DAY and regional rollout of Ortho-K.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Q2\\\",\\\"FY2027 Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[61480,65131]}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Q2\\\",\\\"FY2027 Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit\\\",\\\"data\\\":[5168,6168]}]}}\"}, {\"jir_chart_id\": \"ebitda_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"EBITDA Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Q2\\\",\\\"FY2027 Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"EBITDA\\\",\\\"data\\\":[10003,11473]}]}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Gross Profit Margin, SG&A Ratio, Operating Margin\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Q2\\\",\\\"FY2027 Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Gross Profit Margin\\\",\\\"data\\\":[54.3,53.6]},{\\\"label\\\":\\\"SG&A Ratio\\\",\\\"data\\\":[45.7,44.1]},{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[8.4,9.5]}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Revenue Composition by Segment\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Vision Care\\\",\\\"1DAY\\\",\\\"Ortho-K Related\\\",\\\"Other Contact Lenses & Lens Care\\\"],\\\"datasets\\\":[{\\\"data\\\":[605 - 0, 188, 68, 339]}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Full-Year Guidance and Results\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{\\\"columns\\\":[\\\"Item\\\",\\\"Actual\\\",\\\"Forecast\\\",\\\"Progress\\\"],\\\"rows\\\":[[\\\"Revenue\\\",133000,133000,49.0]]}}\"}]","ir_related_company":9426,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-151807","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n